Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H16N2S2 |
| Molecular Weight | 264.41 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1CCC(CC1)NSC2=NC3=C(S2)C=CC=C3
InChI
InChIKey=DEQZTKGFXNUBJL-UHFFFAOYSA-N
InChI=1S/C13H16N2S2/c1-2-6-10(7-3-1)15-17-13-14-11-8-4-5-9-12(11)16-13/h4-5,8-10,15H,1-3,6-7H2
DescriptionCurator's Comment: Description was created based on several sources, including http://www.fda.gov/downloads/BiologicsBloodVaccines/Allergenics/UCM294327.pdf
Curator's Comment: Description was created based on several sources, including http://www.fda.gov/downloads/BiologicsBloodVaccines/Allergenics/UCM294327.pdf
N-cyclohexyl-2-benzothiazosulfenamide (Sulfenax® CBS) is used in rubber industry in processing of natural and synthetic rubber in rubber compounds as a fast accelerator of vulcanization with delayed action. N-cyclohexyl-2-benzothiazosulfenamide is a chemical allergen. It is used for diagnosis of contact allergy. It is a component of Mercapto Mix, used in the epicutaneous patch test, called T.R.U.E. TEST, approved by FDA in 1994. T.R.U.E. TEST is indicated for use as an aid in the diagnosis of allergic contact dermatitis in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL6099 Sources: http://www.ncbi.nlm.nih.gov/pubmed/21590714 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | T.R.U.E. TEST Approved UseT.R.U.E. TEST is an epicutaneous patch test indicated for use as an aid in the diagnosis of allergic contact dermatitis in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels. Launch Date1993 |
Doses
| Dose | Population | Adverse events |
|---|---|---|
1 % single, topical Studied dose Dose: 1 % Route: topical Route: single Dose: 1 % Sources: |
unhealthy, ADOLESCENT|ADULT Health Status: unhealthy Age Group: ADOLESCENT|ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Contact dermatitis... Other AEs: Contact dermatitis (2.9%) Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Contact dermatitis | 2.9% | 1 % single, topical Studied dose Dose: 1 % Route: topical Route: single Dose: 1 % Sources: |
unhealthy, ADOLESCENT|ADULT Health Status: unhealthy Age Group: ADOLESCENT|ADULT Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Identification of benzothiazole derivatives and polycyclic aromatic hydrocarbons as aryl hydrocarbon receptor agonists present in tire extracts. | 2011-08 |
|
| Development and application of an LC-MS method to determine possible migration of mercaptobenzothiazole, benzothiazole and related vulcanization residues from rubber used in contact with food and drink. | 2003-02 |
Sample Use Guides
Apply the three adhesive panels of allergens and allergen mixes on healthy
skin of the back. Remove panels and evaluate the skin 48 hours after
application. Re-evaluate the skin 72 to 96 hours after application.
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/21590714
10 uM of N-cyclohexyl-2-benzothiazosulfenamide induced AhR-dependent gene expression in mouse hepatoma (H1L6.1c2) cells
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB169427
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
DTXSID5020360
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
SUB61033
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
2868
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
100000134274
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
202-411-2
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
95-33-0
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
7232
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
C044169
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
DB14200
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
N0000175629
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] | ||
|
N0000184306
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
1306886
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | RxNorm | ||
|
UCA53G94EV
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
UCA53G94EV
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | |||
|
N0000171131
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
4809
Created by
admin on Mon Mar 31 18:39:27 GMT 2025 , Edited by admin on Mon Mar 31 18:39:27 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD